We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
Cap. Flow
+$92M
Cap. Flow %
1.84%
Top 10 Hldgs %
38.84%
Holding
3,762
New
250
Increased
1,451
Reduced
1,277
Closed
224

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$18.4M
2
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$9.77M
3
DYNF icon
BlackRock US Equity Factor Rotation ETF
DYNF
+$5.48M
4
MSFT icon
Microsoft
MSFT
+$4.93M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.9M

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$7.34M
2
SBUX icon
Starbucks
SBUX
+$4.7M
3
CMF icon
iShares California Muni Bond ETF
CMF
+$3.3M
4
RSP icon
Invesco S&P 500 Equal Weight ETF
RSP
+$2.63M
5
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$1.7M

Sector Composition

Rank Sector Weight
1 Technology 17.21%
2 Healthcare 9.68%
3 Financials 7.2%
4 Communication Services 5.16%
5 Consumer Discretionary 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABG icon
3051
Asbury Automotive
ABG
$3.85B
$1.67K ﹤0.01%
7
-14
-67% -$3.2K
LQDA icon
3052
Liquidia Corp
LQDA
$8.02B
$1.67K ﹤0.01%
134
– –
PZZA icon
3053
Papa John's
PZZA
$806M
$1.66K ﹤0.01%
34
-304
-90% -$12.4K
TDOC icon
3054
Teladoc Health
TDOC
$1.3B
$1.66K ﹤0.01%
191
-1,621
-89% -$11.7K
WVVI icon
3055
Willamette Valley Vineyards
WVVI
$11.9M
$1.66K ﹤0.01%
300
– –
NATH icon
3056
Nathan's Famous
NATH
$402M
$1.66K ﹤0.01%
15
+4
+36% +$408
BEAM icon
3057
Beam Therapeutics
BEAM
$2.84B
$1.65K ﹤0.01%
97
-18
-16% -$313
DFTX
3058
Definium Therapeutics
DFTX
$6.12B
$1.63K ﹤0.01%
252
+233
+1,226% +$1.53K
AMN icon
3059
AMN Healthcare
AMN
$1.4B
$1.63K ﹤0.01%
79
-30
-28% -$624
DVAX
3060
DELISTED
Dynavax Technologies
DVAX
$1.63K ﹤0.01%
164
-1,892
-92% -$19.9K
NATL icon
3061
NCR Atleos
NATL
$3.44B
$1.63K ﹤0.01%
57
-8
-12% -$216
EGBN icon
3062
Eagle Bancorp
EGBN
$845M
$1.62K ﹤0.01%
83
-19
-19% -$353
QAI icon
3063
NYLI Hedge Multi-Strategy Tracker ETF
QAI
$1.02B
$1.62K ﹤0.01%
50
-1,478
-97% -$46.5K
HTH icon
3064
Hilltop Holdings
HTH
$2.24B
$1.61K ﹤0.01%
53
– –
AVDL
3065
DELISTED
Avadel Pharmaceuticals
AVDL
$1.6K ﹤0.01%
+181
New +$1.59K
BNTX icon
3066
BioNTech
BNTX
$23.5B
$1.6K ﹤0.01%
15
+12
+400% +$1.21K
EVER icon
3067
EverQuote
EVER
$906M
$1.6K ﹤0.01%
66
– –
AAMI
3068
Acadian Asset Management
AAMI
$3.19B
$1.59K ﹤0.01%
45
-25
-36% -$727
NEXT icon
3069
NextDecade
NEXT
$1.78B
$1.58K ﹤0.01%
177
-36
-17% -$279
SWIM icon
3070
Latham Group
SWIM
$880M
$1.58K ﹤0.01%
247
-98
-28% -$570
URTY icon
3071
ProShares UltraPro Russell2000
URTY
$356M
$1.57K ﹤0.01%
40
– –
RLY icon
3072
State Street Multi-Asset Real Return ETF
RLY
$1.29B
$1.57K ﹤0.01%
54
– –
JBTM
3073
JBT Marel
JBTM
$6.39B
$1.56K ﹤0.01%
13
+11
+550% +$1.23K
DLX icon
3074
Deluxe
DLX
$1.15B
$1.56K ﹤0.01%
98
+86
+717% +$1.29K
RYAAY icon
3075
Ryanair
RYAAY
$31.3B
$1.56K ﹤0.01%
27
– –
121 122
123
124 125

Similar funds

HFS
Hantz Financial Services Southfield, Michigan $6.56B AUM 16.11% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Parallel Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q2 2025 filing shows 250 new, 1,451 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
  • Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
  • Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
  • Parallel Advisors opened 250 new positions and closed 224 in Q2 2025.
  • Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.